Saturday 17 October 2026
Export PRE’s income statement to Excel — free account
Prenetics Global Limited
PRE Consumer Defensive Packaged Foods
Prenetics Global Limited’s revenue for fiscal 2025 (year ended December 2025) was $92.4 million, up 479.8% from fiscal 2024. In the quarter to June 2026, revenue grew 288.6%, EPS grew 44.7% and free cash flow fell 297.2%, each against the same quarter a year earlier. Dividend growth for ten consecutive years; insiders bought in the last twelve months.
18.52
1.74
−8.59%
Follow PRE
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
2.14 | 2.73 | 2.40 | 3.91 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(20.90) | (27.06) | (10.14) | (35.01) | |
P/B ratio |
3.55 | 2.71 | 1.42 | 1.15 | |
Price to Tangible BV |
3.55 | 3.81 | 2.01 | 1.21 | |
EV/Sales |
1.81 | 1.93 | 2.15 | 3.83 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(5.09) | (5.35) | (3.31) | (3.48) | |
EV/FCF |
(3.13) | (1.93) | (1.46) | (2.26) | |
Quick Ratio |
1.76 | 4.23 | 1.22 | 0.45 | |
Current Ratio |
4.04 | 5.15 | 2.97 | 2.67 | |
Net Debt/EBITDA |
2.84 | 12.21 | 1.35 | 2.15 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.88 | 0.63 | 0.44 | 0.22 | |
Operating CF/Net income |
1.76 | 0.52 | 2.91 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | — | |
Research and Development Expense of Revenue |
1.63% | 4.01% | 1.53% | 4.97% | |
Selling, General and Administrative Expense of Revenue |
110.49% | 87.74% | 78.64% | 82.42% | |
Intangible Assets out of Total Assets |
0.00 | 0.20 | 0.22 | 0.04 | |
Share Based Compensation of Revenue |
3.70% | 3.45% | 15.65% | 0.00% | |
Graham Net Nets |
0.26 | 0.24 | 0.16 | 0.29 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(21.76%) | (23.71%) | (25.52%) | (27.48%) | |
Free Cash Flow Yield |
(27.11%) | (36.45%) | (61.60%) | (43.30%) | |
Revenue per Share |
2.69 | 2.12 | 3.46 | 1.70 | |
Operating CF per Share |
(0.91) | (0.71) | (1.55) | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.91) | (0.71) | (1.55) | 0.00 | |
Cash per Share |
3.42 | 6.24 | 2.29 | 0.95 | |
Shareholders Equity per Share |
5.38 | 7.13 | 11.13 | 11.60 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
5.38 | 7.13 | 11.13 | 11.60 | |
Free Cash Flow |
(15.79) | (12.12) | (21.83) | — | |
Working Capital |
111.12 | 106.47 | 56.48 | 56.17 | |
Capital Expenditures |
41.34 | — | (54.55) | — | |
Net Current Asset Value |
86.95 | 77.83 | 35.49 | 54.47 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
4.50 | 3.50 | 4.11 | 3.82 | |
Average Payables |
2.99 | 3.05 | 3.41 | 7.33 | |
Average Inventory |
9.14 | 10.40 | 6.80 | 7.14 | |
Average Assets |
176.38 | 189.66 | 209.82 | 216.14 | |
Average Common Equity |
121.91 | 141.07 | 163.86 | 170.65 |
Columns are period end dates